National and Kapodistrian University of Athens
Δράση του ενζύμου μεταλλοπρωτεϊνάση 9 (ΜΜΡ-9) στην ινσουλινοεξαρτώμενη οδό επιβίωσης σε πρωτογενή νευρικά κύτταρα εγκεφάλου από φυσιολογικά και διαγονιδιακά ποντίκια - μοντέλα νόσου Alzheimer
Abstract
dc:descriptionA hallmark of Alzheimer’s disease (AD) is the accumulation of oligomeric amyloid-β (Αβ) peptide, which may be primarily responsible for neuronal dysfunction. Among others, insulin survival pathway is impaired due to the presence of Αβ-oligomers. On the contrary, unperturbed insulin signaling provides a defense mechanism against neuronal loss. Previous studies have shown that matrix metalloproteinase-9 (MMP-9), an enzyme of the extracellular matrix which is implicated in synaptic plasticity, may have a neuroprotective role against AD, by decreasing the formation of Αβ oligomers. In the present study, the role of MMP-9 on the insulin survival pathway was examined in two different experimental systems; in primary hippocampal cultures and hippocampal tissue extracts from 3 month-old wild type mice. Four different mouse genotypes were used; mice model for AD (5XFAD), MMP-9-overexpressing (TgMMP-9) mice, double transgenic mice (5XFAD/TgMMP-9) and wild type mice (WT). The data demonstrate that the insulin pathway was compromised in samples from 5XFAD mice, in both experimental systems, when compared to the wild type and MMP-9 overexpressing mice. This was due to enhanced phosphorylation of IRS1 at Serine 636, which renders IRS1 inactive and prevents insulin-mediated signaling. On the contrary, in 5XFAD/TgMMP-9 samples, the insulin survival pathway was rescued through enhanced activation by phosphorylation of IRS1 at Tyrosine 465, followed by increased levels of BDNF and TrkB activation. Increased phosphorylation of Akt and GSK-3β, and decreased phosphorylation of JNK kinase was observed. Finally, decreased apoptosis, as well as decreased oligomeric Αβ levels, were also observed in 5XFAD/TgMMP-9 mice in vitro and in vivo respectively, compared to 5XFAD mice. In conclusion, our findings indicate that overexpression of MMP-9 is able to rescue insulin survival signaling in vitro and in early stages in the 5XFAD model of AD. Thus, insulin-mediated survival enhancement, via targeted MMP-9 expression, could possibly be used as a novel promising therapeutic strategy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kaminari, Archontia
- Καμινάρη, Αρχοντία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41871